Medical Director, Myelofibrosis

Role Summary

The Medical Director, Myelofibrosis leads medical affairs activities for the US team, applying clinical and scientific expertise to support evidence generation, external engagement, and medical insights for internal stakeholders. The role contributes to medicine strategy, develops and executes tactical plans, supports external engagement, and interprets data to guide medical strategies for Myelofibrosis.

Responsibilities

• Contribute to the development and execution of the US Medical Affairs Plan (UMAP) and strategic launch plans for Myelofibrosis.
• Lead planning and execution of medical tactics, including medical material development, communication plans, and application of customer insights.
• Provide input into the design of Phase IIIB/IV studies and selection of investigator-sponsored studies aligned with global franchises.
• Recommend scientifically appropriate measures within health outcomes research to meet US reimbursement needs.
• Collaborate with field medical teams to lead/contribute to scientific engagement between GSK and external communities to advance understanding of Myelofibrosis, disease management, and patient care.
• Integrate US environment needs and medical voice of customer (patients, providers, payers) into medical affairs strategy.
• Ensure US-specific needs for medical and health outcomes evidence generation are represented in global medical work.
• Apply sound medical governance to all activities, ensuring scientific integrity and compliance.
• Partner with stakeholders to deliver medical activities supporting lifecycle management and optimal patient care.
• Understand, interpret, and apply external environment and competitive knowledge to define the medical story for Myelofibrosis.
• Support the US Medical Affairs Leader (USMAL) or US Executive Medical Lead, Hematology as needed.

Qualifications

• Master‚Äôs Degree, PharmD, PhD, Allied Health Professional or other scientific degree.
• At least 5 years industry experience in a comparable role.
• Preferred: Expertise in oncology or hematology, with a focus on myelofibrosis.
• Preferred: Deep clinical and scientific understanding, including clinical study design for evidence generation and data evaluation.
• Preferred: Awareness of the US healthcare environment and external customer needs.
• Preferred: Strong communication and leadership skills.
• Preferred: Ability to deliver on key responsibilities and adapt to change.
• Preferred: Flexible thinking to analyze external environments and translate insights into strategy.
• Preferred: Customer-driven approach to understanding external needs.
• Preferred: Ability to build relationships and work effectively with others.
• Preferred: Capability to act as a teacher, coach, and mentor to team members.

Skills

• Medical affairs planning and execution
• Evidence generation and health outcomes research
• Scientific engagement and external stakeholder management
• Strategic thinking and medical governance
• Communication and leadership in cross-functional settings

Education

• Master‚Äôs Degree, PharmD, PhD, Allied Health Professional or other scientific degree (required).